●
ASX Company Information
Home
About Us
Products
Investor Relations
Business Development
Contact Us
Announcements
Annual reports
Annual General Meeting
Presentations
Corporate Governance
IPO prospectus
Research coverage
23/07/2010
Appendix 4C June 2010
11/06/2010
Appendix 3B - Release of shares from escrow
28/05/2010
ASX announcement: Release of shares from escrow
24/05/2010
ASX announcement: R&D alliance with global top 10 partner
read more ...
Announcements
23 Jul 2010 -
Appendix 4C June 2010
11 Jun 2010 -
Appendix 3B - Release of shares from escrow
28 May 2010 -
ASX announcement: Release of shares from escrow
24 May 2010 -
ASX announcement: R&D alliance with global top 10 partner
11 May 2010 -
ASX announcement: Partnering with Healthscope on RTI-plex
30 Apr 2010 -
Appendix 4c
19 Apr 2010 -
ASX Announcement: PapType CE marked
05 Mar 2010 -
ASX announcement - expiry of unlisted options
18 Feb 2010 -
Appendix 4D - Half year report to December 2009
10 Feb 2010 -
Appendix 3B: Issue of shares and options
22 Jan 2010 -
Receipt of TGA approval for PapType
11 Dec 2009 -
Appendix 3Y - Mel Bridges
01 Dec 2009 -
Appointment of Chief Financial Officer
30 Nov 2009 -
Appendix 3Y - Change in director's interests
19 Nov 2009 -
Genera submits PapType for TGA review and ARTG listing
05 Nov 2009 -
ASX announcement: Placement to sophisticated and professional investors
22 Oct 2009 -
Appendix 4C
15 Oct 2009 -
Genera receives TGA licence to manufacture
17 Sep 2009 -
2009 Annual Report
04 Sep 2009 -
ASX release: Genera announces major clinical study results
26 Aug 2009 -
Appendix 4E and preliminary final report
19 Aug 2009 -
Appendix 3Y correction
20 Jul 2009 -
ASX release: Update on TGA audit process
15 Jul 2009 -
Appendix 3B: Issuance of new shares
10 Jul 2009 -
ASX announcement - EGM results
15 Jun 2009 -
Corporate update
09 Jun 2009 -
Announcement of EGM
21 May 2009 -
Appendix 3Y and Form 603
18 May 2009 -
ASX release: Genera announces $2.99m placement
30 Apr 2009 -
Appendix 4C and company update
08 Apr 2009 -
ASX release: PapType performs well compared to cytology
02 Apr 2009 -
ASX release - lapsed options
02 Apr 2009 -
Appendix 3B - ESOP allocations
25 Feb 2009 -
ASX release: GBI 4D final report
09 Feb 2009 -
ASX announcement: Options pricing and change to registered office
22 Jan 2009 -
Appendix 4C - December 2008 quarter
08 Jan 2009 -
ASX release: Grant of patent
16 Dec 2008 -
Appendix 3Z: Final director's interest notice: Matt Harris
15 Dec 2008 -
Appendix 3F - Director's initial interests
12 Dec 2008 -
ASX release: Mel Bridges to join the board of Genera Biosystems
12 Dec 2008 -
Appendix 3B: Escrowed shares and lapsed options
09 Dec 2008 -
Appendix 3Y. Change in Director's Interests (FC)
05 Dec 2008 -
Appendix 3Y. Change in Director's Interests (DS)
04 Dec 2008 -
ASX release: ESOP amendment
04 Dec 2008 -
Appendix 3Y. Change in Director's Interests (DS)
01 Dec 2008 -
Appendix 3Y: Change in Director's Interests (KP)
28 Nov 2008 -
ASX release: Release of stock from escrow
26 Nov 2008 -
ASX release: AGM: Chairman's speech
21 Nov 2008 -
Appendix 3B: Issue of options (AB)
17 Nov 2008 -
Appendix 3B: Newly listed shares
11 Nov 2008 -
Appendix 3B: Newly listed shares
31 Oct 2008 -
ASX release: Release from escrow
31 Oct 2008 -
Appendix 4C: Quarterly cashflow
24 Oct 2008 -
ASX release: AGM NOM
15 Oct 2008 -
ASX release: PapType performance in detection of cervical pre-cancer
Sign up to receive our Newsletter